DIC in Pregnancy-Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments

被引:62
作者
Erez, Offer [1 ,2 ]
Othman, Maha [3 ]
Rabinovich, Anat [4 ,5 ]
Leron, Elad [6 ]
Gotsch, Francesca [7 ]
Thachil, Jecko [8 ]
机构
[1] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Matern Dept D, Sch Med,Fac Hlth Sci,Div Obstet & Gynecol, Beer Sheva, Israel
[2] Wayne State Univ, Dept Obstet & Gynecol, Hutzel Womens Hosp, Detroit, MI 48201 USA
[3] Queens Univ, Sch Med, Dept Biomed & Mol Sci, Kingston, ON, Canada
[4] Soroka Univ Med Ctr, Inst Hematol, Thrombosis & Hemostasis Unit, Beer Sheva, Israel
[5] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84101 Beer Sheva, Israel
[6] Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Univ Med Ctr, Div Obstet & Gynecol,Sch Med, Beer Sheva, Israel
[7] Univ Verona, Azienda Osped Univ Integrata, Dept Obstet & Gynecol, AOUI Verona, Verona, Italy
[8] Manchester Royal Infirm, Dept Haematol, Manchester, Lancs, England
关键词
DIC; hyperfibrinolysis; thrombin; pregnancy specific DIC score; maternal mortality; placental abruption; DISSEMINATED INTRAVASCULAR COAGULATION; ACUTE FATTY LIVER; FACTOR PATHWAY INHIBITOR; AMNIOTIC-FLUID EMBOLISM; ACTIVATED FACTOR-VII; VISCOELASTIC TESTING TEG/ROTEM; HUMAN SOLUBLE THROMBOMODULIN; POSTPARTUM HEMORRHAGE OBS2; MOLECULAR-WEIGHT HEPARIN; CRITICALLY-ILL PATIENTS;
D O I
10.2147/JBM.S273047
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obstetrical hemorrhage and especially DIC (disseminated intravascular coagulation) is a leading cause for maternal mortality across the globe, often secondary to underlying maternal and/or fetal complications including placental abruption, amniotic fluid embolism, HELLP syndrome (hemolysis, elevated liver enzymes and low platelets), retained stillbirth and acute fatty liver of pregnancy. Various obstetrical disorders can present with DIC as a complication; thus, increased awareness is key to diagnosing the condition. DIC patients can present to clinicians who may not be experienced in a variety of aspects of thrombosis and hemostasis. Hence, DIC diagnosis is often only entertained when the patient already developed uncontrollable bleeding or multi-organ failure, all of which represent unsalvageable scenarios. Beyond the clinical presentations, the main issue with DIC diagnosis is in relation to coagulation test abnormalities. It is widely believed that in DIC, patients will have prolonged prothrombin time (PT) and partial thromboplastin time (PTT), thrombocytopenia, low fibrinogen, and raised D-dimers. Diagnosis of DIC can be elusive during pregnancy and requires vigilance and knowledge of the physiologic changes during pregnancy. It can be facilitated by using a pregnancy specific DIC score including three components: 1) fibrinogen concentrations; 2) the PT difference - relating to the difference in PT result between the patient's plasma and the laboratory control; and 3) platelet count. At a cutoff of >= 26 points, the pregnancy specific DIC score has 88% sensitivity, 96% specificity, a positive likelihood ratio (LR) of 22, and a negative LR of 0.125. Management of DIC during pregnancy requires a prompt attention to the underlying condition leading to this complication, including the delivery of the patient, and correction of the hemostatic problem that can be guided by point of care testing adjusted for pregnancy.
引用
收藏
页码:21 / 44
页数:24
相关论文
共 199 条
[1]   Evaluation and management of postpartum hemorrhage: consensus from an international expert panel [J].
Abdul-Kadir, Rezan ;
McLintock, Claire ;
Ducloy, Anne-Sophie ;
El-Refaey, Hazem ;
England, Adrian ;
Federici, Augusto B. ;
Grotegut, Chad A. ;
Halimeh, Susan ;
Herman, Jay H. ;
Hofer, Stefan ;
James, Andra H. ;
Kouides, Peter A. ;
Paidas, Michael J. ;
Peyvandi, Flora ;
Winikoff, Rochelle .
TRANSFUSION, 2014, 54 (07) :1756-1768
[2]   Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis [J].
Aharon, A ;
Brenner, B ;
Katz, T ;
Miyagi, Y ;
Lanir, N .
THROMBOSIS AND HAEMOSTASIS, 2004, 92 (04) :776-786
[3]   Tranexamic Acid for Prevention and Treatment of Postpartum Hemorrhage: An Update on Management and Clinical Outcomes [J].
Ahmadzia, Homa K. ;
Phillips, Jaclyn M. ;
Katler, Quinton S. ;
James, Andra H. .
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2018, 73 (10) :587-594
[4]   Prophylactic Use of Tranexamic Acid for Postpartum Bleeding Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J].
Alam, Asim ;
Choi, Stephen .
TRANSFUSION MEDICINE REVIEWS, 2015, 29 (04) :231-241
[5]   Use of recombinant activated factor VII in primary postpartum hemorrhage -: The northern European registry 2000-2004 [J].
Alfirevic, Zarko ;
Elbourne, Diana ;
Pavord, Sue ;
Bolte, Antoinette ;
Van Geijn, Herman ;
Mercier, Frederic ;
Ahonen, Jouni ;
Bremme, Katarina ;
Bodker, Birgit ;
Magnusdottir, Ebba Margret ;
Salvesen, Kjell ;
Prendiville, Walter ;
Truesdale, Ann ;
Clemens, Felicity ;
Piercy, Deborah ;
Gyte, Gill .
OBSTETRICS AND GYNECOLOGY, 2007, 110 (06) :1270-1278
[6]  
American College of Obstetricians and Gynecologists, 2006, Obstet Gynecol, V108, P1039
[7]   Systematic review of viscoelastic testing (TEG/ROTEM) in obstetrics and recommendations from the women's SSC of the ISTH [J].
Amgalan, Ariunzaya ;
Allen, Terrence ;
Othman, Maha ;
Ahmadzia, Homa K. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (08) :1813-1838
[8]   TEG in pregnancy: Current challenges and future potential applications [J].
Amgalan, Ariunzaya ;
Othman, Maha .
THROMBOSIS RESEARCH, 2020, 191 :140-141
[9]  
Anas AA, 2010, NETH J MED, V68, P147
[10]   Thrombin-inhibitor complexes in the blood during and after delivery [J].
Andersson, T ;
Lorentzen, B ;
Hogdahl, H ;
Clausen, T ;
Mowinckel, MC ;
Abildgaard, U .
THROMBOSIS RESEARCH, 1996, 82 (02) :109-117